Organisation

International Foundation Alzheimer's Research

Pagina-navigatie:

Main
Current research (24)
Completed research (82)

Completed research

(the most recent research is at the top)
Financier	DNA methylation in Alzheimer?s disease
Financier	Insulin dysregulation as precursor to Alzheimer?s disease
Financier	Mechanism of oxidative stress in Alzheimer?s disease
Financier	BDNF: the bridge between depression and Alzheimer?s disease
Financier	Neural stem cells in a presenilin model of familial AD
Financier	Development of analogues of new drug dimebon
Financier	The microtubule regulating protein RB3 in Alzheimer's disease
Financier	Oxidized cerebrospinal fluid proteins as possible biomarkers for AD
Financier	Diet and cognitive decline in middle-aged men and women
Financier	Endothelial progenitor cells in Alzheimer?s disease
Financier	Alzheimer pathology and the cell cycle; cause or effect?
Financier	Compensatory connectivity and the risk of Alzheimer?s disease
Financier	Early prediction of Alzheimers disease
Financier	Longitudinal in vivo assessment of Aß in early AD using PET
Financier	Neuroprotection in the OBX model of Alzheimer?s disease
Financier	The regulation of cerebral perfusion in patients with Alzheimer's disease
Financier	Phosphodiesterase inhibition in Alzheimer's disease
Financier	Infection and Inflammation as etiological factors in Alzheimer's disease.
Financier	Depression as a risk factor for Alzheimer's disease
Financier	In vivo µMRI and MRS studies in assessment of early biomarkers of AD
Financier	Facilitation of human post mortem research of Alzheimer's disease
Financier	Modeling Familial Alzheimer's Disease in Zebrafish
Financier	Endoplasmic Reticulum stress as therapeutic target in AD
Financier	Small heat shock proteins and inflammation in Alzheimer's disease
Financier	A genome wide search for genes involved in plasma Abeta42/40 levels
Financier	Insulin metabolism and risk of dementia
Financier	Non-viral neprilysin gene targeting technology for treating Alzheimer's Disease
Financier	Functional connectivity and the risk of Alzheimer?s disease
Financier	The effect of the biological clock on Alzheimer's Disease
Financier	Cerebrovascular dysfunction in Alzheimer and MCI
Financier	Methylphenidate and the pathogenesis of apathy in AD
Financier	Key proteins of the ubiquitin-proteasome system in AD
Financier	Dendrite and spine morphology in a novel transgenic mouse model of Alzheimer's disease
Financier	In vitro testing of therapeutics for Alzheimer's disease
Financier	Determinants of change in hippocampal volume on MRI
Financier	Enhanced tryptophan catabolism in the Alzheimer brain
Financier	Mixed memories: neurotransmitter interactions in Memory
Financier	Functional activities of Alzheimer neurons
Financier	Can sleep therapy increase functional connectivity in early dementia?
Financier	Imaging of amyloid in pre-symptomatic Alzheimer's disease
Financier	Endoplasmic reticulum stress in Alzheimer's disease
Financier	A test bank: efficient testing and screening for AD
Financier	Cerebrovascular effects of cholinesterase inhibitors
Financier	Depression and Alzheimer disease: is stress the missing link?
Financier	A novel A-beta epitope as target of specific antibodies
Financier	Collateral circulation, growth factors and cognition
Financier	Heat shock proteins as antagonist of amyloid-beta protein
Financier	Relation between sex hormone receptors and Alzheimer associated changes
Financier	Improvement of dementia diagnosis in general practice
Financier	The role of MAP-tau in neurodegeneration
Financier	Genetic effect of inflammation reactions as risk factor for Alzheimer's disease
Financier	Apolipoprotein E influences cerebral cholesterol homeostasis
Financier	Genetic predisposition of white matter lesions (WML) in the brain
Financier	Cognitive training in Alzheimer's disease, assessment with fMRI, H-MRS and DTI
Financier	The prediction of the development of Alzheimer's disease with serial MRI-scans
Financier	Amyloid-associated factors in Alzheimer's disease
Financier	A novel A-beta epitope as target of specific antibodies
Financier	Cholesterol metabolism in Alzheimer's disease
Financier	Non-viral neprilysin gene targetting technology for treating Alzheimer's disease
Financier	Mechanism of neuronal loss in APP-transgenic mice
Financier	Proteomics in Alzheimer's disease
Financier	Genetic determinants of cognitive functions
Financier	Metabolic syndrome and inflammations as risk factors for cognitive decline
Financier	Microglial activation and neuronal changes in Alzheimer's disease
Financier	On the role of alpha1-antichymotrypsin in Alzheimer's disease
Financier	Carbon metabolism and markers of cognitive decline
Financier	Glial-specific proteins in neurons of Alzheimer patients
Financier	Single cell profiling of young and aged neurons in mouse and human
Financier	Brain changes in behaviourally disturbed Alzheimer patients
Financier	Mobilization of oxidants against Alzheimer's disease
Financier	Infections as cofactor of vascular dementia
Financier	Prediction of dementia among persons with memory symptoms
Financier	Inflammation markers as risk factor of the early stage (MCI) of Alzheimer's disease
Financier	The role of apoE in Ab toxicity
Financier	The action of the thyroid gland and the risk of Alzheimer's disease
Financier	The Dutch Brain Bank - an essential facility in Alzheimer research
Financier	Reactivation and sprouting of post-mortem Alzheimer neurons
Financier	Regulation of APP transport
Financier	The specificity of hippocampus atrophy in Alzheimer's disease
Financier	Subcellular localization of the active gamma-secretase complex
Financier	Neuronal COX-2 expression and cell cycle activation in Alzheimer's disease
Financier	Frameshift mutations, neuronal cell physiology and Alzheimer